Literature DB >> 10739808

Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation.

M Nogueira1, J Cartwright, K Horn, N Doe, S Shappell, R Barrios, E Coroneos, L D Truong.   

Abstract

Thin basement membrane disease (TBMD) is a condition originally defined as diffuse thinning of the glomerular basement membrane (GBM) associated with hematuria in all patients. Although proteinuria has been described in up to 60% of patients with TBMD, it is almost always mild, with a 24-hour excretion mostly of less than 500 mg. We describe eight patients (four men and four women between 32 and 66 years of age) with TBMD who presented with heavy proteinuria or nephrotic syndrome. Among the seven cases with family history, hematuria was noted in five. All patients had a long history of microscopic hematuria, with episodic gross hematuria in two. Renal biopsies showed diffuse thinning of the GBM in each patient (mean between 185.3 x 29.8 nm and 232.6 x 34.5 nm versus control between 325 x 35 nm and 350 x 15 nm). Three cases showed thinning of GBM only (group I); the remaining five cases showed thinning of GBM associated with focal segmental glomerulosclerosis. All three patients of group I presented with nephrotic syndrome and normal renal function. Treatment with steroids resulted in remission of nephrotic syndrome in two, whereas nephrotic syndrome persisted in the untreated patient. Among the five patients in group II, nephrotic syndrome and normal renal function at presentation were noted in two, whereas the other three had heavy proteinuria (2.2, 2. 5, and 2.6 g/d, respectively) associated with mildly decreased renal function (serum creatinine 1.8, 1.3, and 1.5 mg/dL, respectively). At last follow-up, although the renal function was stable in all five, only the three who received steroid treatment had remission or marked improvement of proteinuria. Hematuria, however, persisted in all eight patients of both groups. Whether specific gene mutations are translated into structural changes responsible for both excessive GBM thinning and increased transcapillary permeability remains to be elucidated. Alternatively, the heavy proteinuria/nephrotic syndrome may not be related to TBMD, but rather is the manifestation of associated glomerular diseases. Follow-up, including a response to steroids, supports the latter hypothesis.

Entities:  

Mesh:

Year:  2000        PMID: 10739808     DOI: 10.1016/s0272-6386(00)70033-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Thin basement membrane nephropathy associated with minimal change disease in a 15-year-old boy.

Authors:  Shuichiro Fujinaga; Kazunari Kaneko; Yoshiyuki Ohtomo; Hitohiko Murakami; Mayako Takemoto; Masaru Takada; Toshiaki Shimizu; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

Review 2.  The expanding phenotypic spectra of kidney diseases: insights from genetic studies.

Authors:  Marijn F Stokman; Kirsten Y Renkema; Rachel H Giles; Franz Schaefer; Nine V A M Knoers; Albertien M van Eerde
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

Review 3.  The role of molecular genetics in diagnosing familial hematuria(s).

Authors:  Constantinos Deltas; Alkis Pierides; Konstantinos Voskarides
Journal:  Pediatr Nephrol       Date:  2011-06-19       Impact factor: 3.714

4.  Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy.

Authors:  Hande Aypek; Christoph Krisp; Shun Lu; Shuya Liu; Dominik Kylies; Oliver Kretz; Guochao Wu; Manuela Moritz; Kerstin Amann; Kerstin Benz; Ping Tong; Zheng-Mao Hu; Sulaiman M Alsulaiman; Arif O Khan; Maik Grohmann; Timo Wagner; Janina Müller-Deile; Hartmut Schlüter; Victor G Puelles; Carsten Bergmann; Tobias B Huber; Florian Grahammer
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

5.  Multiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment.

Authors:  Angel M Sevillano; Eduardo Gutierrez; Enrique Morales; Eduardo Hernandez; Maria Molina; Ester Gonzalez; Manuel Praga
Journal:  Clin Kidney J       Date:  2014-04-15

Review 6.  How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.

Authors:  Aya Imafuku; Kandai Nozu; Naoki Sawa; Koichi Nakanishi; Yoshifumi Ubara
Journal:  Clin Exp Nephrol       Date:  2020-03-30       Impact factor: 2.801

7.  Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.

Authors:  Andrew F Malone; Paul J Phelan; Gentzon Hall; Umran Cetincelik; Alison Homstad; Andrea S Alonso; Ruiji Jiang; Thomas B Lindsey; Guanghong Wu; Matthew A Sparks; Stephen R Smith; Nicholas J A Webb; Philip A Kalra; Adebowale A Adeyemo; Andrey S Shaw; Peter J Conlon; J Charles Jennette; David N Howell; Michelle P Winn; Rasheed A Gbadegesin
Journal:  Kidney Int       Date:  2014-09-17       Impact factor: 10.612

8.  Thin basement membrane nephropathy: is there genetic predisposition to more severe disease?

Authors:  Constantinos Deltas
Journal:  Pediatr Nephrol       Date:  2008-11-19       Impact factor: 3.714

9.  A novel heterozygous variant of the COL4A4 gene in a Chinese family with hematuria and proteinuria leads to focal segmental glomerulosclerosis and chronic kidney disease.

Authors:  Liang-Liang Fan; Lv Liu; Fang-Mei Luo; Ran Du; Chen-Yu Wang; Yi Dong; Ji-Shi Liu
Journal:  Mol Genet Genomic Med       Date:  2020-11-07       Impact factor: 2.183

10.  Clinical and pathohistological characteristics of Alport spectrum disorder caused by COL4A4 mutation c.193-2A>C: a case series.

Authors:  Petar Šenjug; Tamara Nikuševa Martić; Marija Šenjug Perica; Maja Oroz; Matija Horaček; Kristina Gotovac Jerčić; Krešimir Galešić; Danica Galešić Ljubanović
Journal:  Croat Med J       Date:  2021-06-30       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.